Population-level behavioral and structural drivers of COVID-19 vaccine uptake in the US.

Publication date: Jul 20, 2026

Substantial variation in COVID-19 vaccination trends across U. S. communities raises key questions about the factors that shape vaccination uptake. We develop a dynamic simulation model that captures population-driven feedback processes, from social influence and uptake heterogeneity to fear of infection, responses to vaccine availability, and capacity constraints. To estimate behavioral parameters, we derive an ordinary differential equation (ODE)-informed Tobit regression framework and apply it to weekly vaccination data from all 50 US states and the District of Columbia during 2021-2022. The resulting estimates provide a robust empirical foundation for model calibration. The calibrated model reproduces observed regional vaccination trajectories and reveals three distinct phases of uptake: an early phase in which capacity and eligibility constraints bind on the underlying demand, a middle phase in which behavioral responses to changing COVID-19 incidence shape the fluctuations in uptake, with rising case numbers stimulating additional vaccination; and a late phase shaped by saturation dynamics. Finally, we document substantial regional heterogeneity in responsiveness to infection risk and the overall tendency to vaccinate when capacity permits.

Open Access PDF

Concepts Keywords
Behavioral
Capacity
Constraints
Covid
Heterogeneity
Infection
Level
Phase
Population
Regional
Shape
Substantial
Uptake
Vaccination
Vaccine

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease MESH infectious diseases
disease MESH respiratory diseases
disease MESH influenza
disease MESH measles
pathway KEGG Measles
disease MESH mumps
disease MESH rubella
pathway REACTOME Reproduction
disease MESH included
disease MESH death
disease MESH fed
disease MESH tic
disease MESH ics
disease MESH char
drug DRUGBANK Ranitidine
drug DRUGBANK Minaprine
disease MESH Dis
drug DRUGBANK Isosorbide Mononitrate
drug DRUGBANK Dimethyl sulfone
drug DRUGBANK Morpholinylmercaptobenzothiazole
disease MESH mbs

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *